| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/1999 | CA2304719A1 Modulation of nitric oxide production |
| 04/08/1999 | CA2304665A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | CA2304484A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 04/08/1999 | CA2304209A1 Ras-binding protein (pre1) |
| 04/08/1999 | CA2303401A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
| 04/08/1999 | CA2212606A1 A target for pre-symptomatic detection, control and prevention of multiple sclerosis in humans |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth) |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906954A1 Amino-terminal truncated c-c chemokines as chemokine antagonist |
| 04/07/1999 | EP0906953A1 Allelic variant of human stat3 |
| 04/07/1999 | EP0906951A2 Storage of materials |
| 04/07/1999 | EP0906919A2 Novel integrin-binding peptides |
| 04/07/1999 | EP0906918A2 Process for production of insulin precursors having correctly linked cystein bridges |
| 04/07/1999 | EP0906915A1 Preparation of cyclic peptide antifungal agents |
| 04/07/1999 | EP0906760A1 Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof |
| 04/07/1999 | EP0906577A1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 04/07/1999 | EP0906576A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 04/07/1999 | EP0906571A1 Labelling and selection of molecules |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906434A1 Mch4 AND Mch5, APOPTOTIC PROTEASE, NUCLEIC ACIDS ENCODING AND METHODS OF USE |
| 04/07/1999 | EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells |
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906427A1 Characterization of transfer factors and methods of use |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906425A2 Vasoactive amine binding molecules |
| 04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
| 04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906417A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
| 04/07/1999 | EP0906340A1 Purification of factor viii complex by immunoaffinity chromatography |
| 04/07/1999 | EP0906339A2 Receptor and transporter antagonists |
| 04/07/1999 | EP0906338A1 Glucagon-like peptide-2 analogs |
| 04/07/1999 | EP0906336A1 Antibiotic producing microbe |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906122A2 Activated linkers and methods for making and purifying the same |
| 04/07/1999 | EP0906121A1 Vasoactive effects and free radical generation by beta-amyloid peptides |
| 04/07/1999 | EP0906120A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide |
| 04/07/1999 | EP0906119A1 Method of treatment |
| 04/07/1999 | EP0906118A1 Method for treating inflammation |
| 04/07/1999 | EP0906117A1 Method for treating or preventing ischemia-reperfusion injury |
| 04/07/1999 | EP0906115A1 COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| 04/07/1999 | EP0906099A1 A method of treating cancer |
| 04/07/1999 | EP0906098A1 Virginiamycin mixture |
| 04/07/1999 | EP0906020A1 Antifungal compositions |
| 04/07/1999 | EP0854716A4 Androgenic directed compositions |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0752884A4 Method of treating auto-immune diseases using type one interferons |
| 04/07/1999 | EP0697882A4 Use of glutathione diesters |
| 04/07/1999 | EP0659181B1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0625198B1 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 04/07/1999 | EP0625164B1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/07/1999 | EP0600868B1 Recombinantly produced lipases for therapeutical treatment |
| 04/07/1999 | EP0569531B1 Stabilized antibody fragments |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213379A Peptide derivatives |
| 04/07/1999 | CN1213378A Antitumor substance extracted from Grifola |
| 04/07/1999 | CN1213326A Filtration of plasma mixtures using cellulose-based filter aids |
| 04/07/1999 | CN1213313A Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/07/1999 | CN1213309A Control of healing process |
| 04/07/1999 | CN1213282A Oral peptide pharmaceutical products |
| 04/07/1999 | CN1213004A Recombination leukocyte mesonium-2 adenovirus carrier and producing method |
| 04/07/1999 | CN1212967A Parathormone related protein human source antibody and its preparation method |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/07/1999 | CN1042797C Antibiosis and antiviral oral liquor |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892113 Protease inhibitors |
| 04/06/1999 | US5892112 Acylation of amino acids with anhydrides or carboxy groups, amidation with amine and conversion of acid or ester to hydroxamic acid and hydrolysis |
| 04/06/1999 | US5892052 Process for making retroviral protease inhibiting compounds |
| 04/06/1999 | US5892020 Multivalent single chain antibodies |
| 04/06/1999 | US5892017 Recombinantly produced pf4ars are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. the antibodies are advantageously used in the prevention and treatment of |
| 04/06/1999 | US5892016 This invention relates to nucleic acid and amino acid sequences of a novel human tumor suppressor and to the use of these sequences in the diagnosis,prevention, and treatment of cancer and autoimmune diseases. |
| 04/06/1999 | US5892015 Human rhombotin-like protein |
| 04/06/1999 | US5892014 DNA encoding a protease-activated receptor 3 |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5892005 High molecular and low molecular fractions of von willebrand factor |
| 04/06/1999 | US5892004 Method for preparing PACAP receptor protein |
| 04/06/1999 | US5892003 Ciliary neurotrophic factor receptor antibodies |
| 04/06/1999 | US5892001 Epithelium-derived T-cell factor antibodies |
| 04/06/1999 | US5892000 From hybridomas 2g6 and b14; for immunoassay test kit used in diagnosis of athlerosclerosis and diabetes |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891914 Bioactive topical siloxane compositions having enhanced performance and safety |
| 04/06/1999 | US5891869 Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics |
| 04/06/1999 | US5891858 Transforming growth factor alpha, treating prostate cancer |
| 04/06/1999 | US5891857 Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
| 04/06/1999 | US5891852 Serine protease inhibitors-cycloheptane derivatives |